China · Delayed Price · Currency is CNY Frontier Biotechnologies Company Description
Frontier Biotechnologies Inc., a commercial-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes various medicines that improve patient health in China.
The company’s medicines address the unmet medical needs of patients in the areas of anti-HIV treatment and pain management.
It offers Aikening, a long-acting HIV fusion inhibitor for the treatment of HIV infection and AIDS. The company’s products in development include small RNA drugs, such as FB7011/FB7013/FB7014 to treat IgA nephropathy, FB7022/FB7021 for dyslipidemia, and FB7012/FB7041/FB7031/FB7032 for various other diseases, including hyperuricemia and gout, tumors, and metabolic-associated fatty liver diseases; FB4001, to treat patients with osteoporosis or high risk of fracture; and FB3002, for the treatment of pain in muscles, bones, and joints.
Frontier Biotechnologies Inc. was founded in 2002 and is headquartered in Nanjing, China.
| Country | China |
| Founded | 2002 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 302 |
| CEO | Dong Xie |
Contact Details
Address: Building E-2, Green Window Nanjing, 211199 China | |
| Phone | 86 25 6964 8375 |
| Website | frontierbiotech.com |
Stock Details
| Ticker Symbol | 688221 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Dong Xie Ph.D. | Founder, Chairman, President and Chief Scientific Officer |
| Qi Shao | Senior Vice President, Chief Operating Officer and Chief Financial Officer |
| Dr. Rongjian Lu Ph.D. | Chief Technology Officer and Director |
| Hangzhou Lv | Senior Vice President of Marketing and Sales |
| Dr. Changjin Wang Ph.D. | MD, CBO and Director |
| Qianya Gao | Vice President, Deputy GM and Secretary of the Board of Directors |
| Xin Guan | Accounting Supervisor |
| Yuting Zhu | Supervisor and Deputy GM Administrative Director |
| Michael Hu | C.M.O. |
| Michael Wang | Senior Vice President and Head of Infectious Diseases Therapy Area |